Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-15

Clinical Trial Update: A Single-blind RCT to Investigate the Effect of Alendronate on Knee Function Following ACLR [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial investigates whether alendronate affects knee function after ACL reconstruction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • alendronate (alendronate)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: ACL Reconstruction | Phase 4 | Status: UNKNOWN